The concept of market Share in the Subdural Hematoma Treatment Market is a direct reflection of the commercial success and clinical differentiation achieved by competing therapeutic modalities, especially in the high-growth Chronic SDH Segment. Share is often measured by the volume of procedures performed using a Key Manufacturer's devices (surgical or endovascular) or the number of...